5-MEMBERED RING COMPOUNDS
    2.
    发明授权
    5-MEMBERED RING COMPOUNDS 有权
    五成分环化合物

    公开(公告)号:EP1106624B1

    公开(公告)日:2003-04-09

    申请号:EP99937011.7

    申请日:1999-08-10

    申请人: TAKARA BIO INC.

    CPC分类号: C07K5/0215 A61K38/00

    摘要: 5-Membered ring compounds represented by general formula (I), optically active isomers thereof or salts of the same. These compounds have physiological activities including a carcinostatic effect. In said formula the bond shown by the dotted line in the 5-membered ring represents that this 5-membered ring may be either a cyclopentene ring having a double bond or a saturated cyclopentane ring, and when the 5-membered ring is a cyclopentene ring, X is OR1, Y is =O and Z is H, and when it is a cyclopentane ring, X is =O, Y is OR2 and Z is OR3, (wherein R1 is R4 or -(CO)-R5; R2 is H,-R6 or -(CO)-R7; and R3 is H, R8 or (CO)-R9 (wherein R4, R5, R6, R7, R8 and R9 are the same or different and each represents an aliphatic, aromatic or aliphatic aromatic group, and R5, R7 and R9 may be each H), provided that the case where R2=R3=H is excluded); and W represents a residue obtained by eliminating SH from an SH-containing compound.

    摘要翻译: 由通式(I)表示的5元环化合物,其光学活性异构体或其盐。 这些化合物具有包括制癌作用在内的生理活性。 在所述式中,五元环中由虚线表示的键表示该5元环可以是具有双键的环戊烯环或饱和的环戊烷环,并且当5元环是环戊烯环时 X是OR1,Y是= O且Z是H,并且当它是环戊烷环时,X是= O,Y是OR2并且Z是OR3,(其中R1是R4或 - (CO)-R5; R2是 (CO)-R7;和R3是H,R8或(CO)-R9(其中R4,R5,R6,R7,R8和R9相同或不同并且各自代表脂族,芳族或 脂族芳族基团,并且R5,R7和R9可以各自为H),条件是排除R2 = R3 = H的情况)。 W表示从含SH化合物中除去SH得到的残基。

    Anti aptotosis AGENTS
    6.
    发明授权
    Anti aptotosis AGENTS 有权
    抗凋亡剂

    公开(公告)号:EP1086952B1

    公开(公告)日:2007-08-15

    申请号:EP99923961.9

    申请日:1999-06-08

    申请人: TAKARA BIO INC.

    IPC分类号: C07D493/08

    摘要: Therapeutic or preventive agents for diseases requiring apoptosis induction, cancerous diseases, diseases requiring the inhibition of active oxygen production, those requiring the inhibition of nitrogen monoxide production, those requiring the inhibition of prostaglandin synthesis, those requiring the inhibition of synovial cell proliferation, those requiring the induction of heat shock protein production or those requiring the inhibition of α-glycosidase, which contain as the active ingredient compounds selected from among compounds represented by general formula (I), (wherein X and Y are each H or CH2OH, provided that when X is CH2OH, Y is H, while when X is H, Y is CH2OH), those represented by general formula (II), (wherein R is a residue obtained by freeing a compound having an SH group from the SH group) and salts of both; and foods, drinks, cosmetics and so on, containing compounds selected from among compounds of general formula (I), those of general formula (II) and salts of both.

    SULFATED FUCOGLUCURONOMANNAN
    7.
    发明公开
    SULFATED FUCOGLUCURONOMANNAN 审中-公开
    苏州富士康

    公开(公告)号:EP1380641A1

    公开(公告)日:2004-01-14

    申请号:EP02720484.1

    申请日:2002-04-18

    申请人: TAKARA BIO INC.

    摘要: An enzyme which decomposes a sulfated fucoglucuronomannan and is useful in the field of glycotechnology; a process for producing the enzyme; a fucoidan fraction reduced in the number of the kinds of molecules and useful as a reagent in glycotechnology; a sulfated fucoglucuronomannan oligosaccharide; and processes for producing the fraction and oligosaccharide.

    摘要翻译: 一种分解硫酸化葡萄糖葡萄糖甘露聚糖的酶,可用于糖业技术领域; 一种生产酶的方法; 岩藻依聚糖级分减少了分子数目,可用作糖酵母中的试剂; 硫酸化的葡萄糖葡萄糖苷寡糖; 以及生产级分和寡糖的方法。